Trader Mw
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
- Colorectal Cancer Treatments and Studies
- Hematology top 10%
Papers in
-
- Cancer therapeutics and mechanisms 7
-
- Synthesis and biological activity 3
- Click Chemistry and Applications 2
- Synthesis and Characterization of Heterocyclic Compounds 2
- Co-authors
- Schabel Fm (15 shared papers)Laster Wr (14 shared papers)Griswold Dp (5 shared papers)Corbett Th (4 shared papers)Skipper He (7 shared papers)Wilcox Ws (2 shared papers)Linda Simpson‐Herren (2 shared papers)Emil Frei (1 shared paper)
- Journals
- Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)PubMed (15 papers)
- Partner nations
- United States
In The Last Decade
Trader Mw
16 papers receiving 619 citations
Trader Mw's Hit Papers
Peers
Comparison fields: 5 of 70
- Oncology 402
- Hematology 75
- Otorhinolaryngology 23
- Pulmonary and Respiratory Medicine 152
- Molecular Biology 290
Countries citing papers authored by Trader Mw
This map shows the geographic impact of Trader Mw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trader Mw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trader Mw more than expected).
Fields of papers citing papers by Trader Mw
This network shows the impact of papers produced by Trader Mw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trader Mw. The network helps show where Trader Mw may publish in the future.
Co-authors
The 10 scholars most cited alongside Trader Mw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. Hit paper breakdown → | 1980 | 357 |
| 2 | Establishment of cross-resistance profiles for new agents. | 1983 | 92 |
| 3 | Concepts for controlling drug-resistant tumor cells. | 1980 | 43 |
| 4 | Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents. | 1982 | 37 |
| 5 | Experimental evaluation of potential anticancer agents. XIX. Sensitivity of nondividing leukemic cell populations to certain classes of drugs in vivo. | 1965 | 35 |
| 6 | Spontaneous AK leukemia (lymphoma) as a model system. | 1969 | 26 |
| 7 | Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy. | 1987 | 25 |
| 8 | Basic and therapeutic trial results obtained in the spontaneous AK leukemia (lymphoma) model-end of 1971. | 1972 | 23 |
| 9 | Response to therapy of spontaneous, first passage, and long passage lines of AK leukemia. | 1969 | 23 |
| 10 | Experimental evaluation of potential anticancer agents. 28. Effects of therapy on viability and rate of proliferation of leukemic cells in various anatomic sites. | 1965 | 17 |
| 11 | Combination chemotherapy for spontaneous AKR lymphoma. | 1974 | 11 |
| 12 | Experimental evaluation of potential anticancer agents. XX. Development of immunity to leukemia L1210 in BDF mice and effects of therapy. | 1966 | 11 |
| 13 | Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors. | 1978 | 7 |
| 14 | Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide. | 1978 | 7 |
| 15 | Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU. | 1976 | 3 |
| 16 | Synergistic antileukemic activity of combinations of two nitrosoureas. | 1981 | 1 |
About Trader Mw
Trader Mw is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Public Health, Environmental and Occupational Health and Genetics, having authored 16 papers that have together received 718 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Acute Lymphoblastic Leukemia research (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Synthesis and biological activity (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Click Chemistry and Applications (2 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (402 citations), Hematology (75 citations), Otorhinolaryngology (23 citations), Pulmonary and Respiratory Medicine (152 citations) and Molecular Biology (290 citations). Trader Mw has collaborated with scholars based in United States. Frequent co-authors include Schabel Fm, Laster Wr, Griswold Dp, Corbett Th, Skipper He, Wilcox Ws, Linda Simpson‐Herren, Emil Frei, WP Peters and Brockman Rw. Their work appears in journals such as Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.